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Abstract
Direct reprogramming represents an easy technique to generate induced hepato-
cytes (iHeps) from somatic cells. However, current protocols are accompanied by
several drawbacks as iHeps are heterogenous and lack fully mature phenotypes of
primary hepatocytes. Here, we established a polycistronic expression system to
induce the direct reprogramming of mouse embryonic fibroblasts towards hepato-
cytes. The resulting iHeps are homogenous and display key properties of primary
hepatocytes, such as expression of hepatocyte markers, albumin secretion, and
presence of liver transaminases. iHeps also possess the capacity to repopulate
decellularized liver tissue and exhibit enhanced hepatic maturation. As such, we
present a novel strategy to generate homogenous and functional iHeps for
applications in tissue engineering and cell therapy.
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1 | INTRODUCTION
Currently, orthotopic liver transplantation is the only cure for severe
acute and chronic liver diseases. Unfortunately, the shortage of donor
livers is a growing problem. In Europe alone, 22% of the patients die while
on the waiting list for a liver transplant (Brangel & Undine, 2016).
Therefore, the development of new therapeutic strategies such as stem
cell transplantation is of utmost importance. Although several types of
stem cells show the potential to be differentiated into hepatocyte‐like
cells, the procurement of the stem cells as well as differentiation
protocols is inefficient, incomplete, and still far from application in human
medicine (Schwartz, Fleming, Khetani, & Bhatia, 2014; Wu & Tao, 2012).
© 2018 The Authors. Biotechnology and Bioengineering Published by Wiley Periodicals, Inc.
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One promising alternative for generating hepatocytes is the
direct reprogramming technique. As from the first direct reprogram-
ming experiments inducing myoblasts over 30 years ago, more and
more types of tissue have been generated with this technique
(Kelaini, Cochrane, & Margariti, 2014). Transcription factors together
with other epigenetic modifiers coordinately play an important role
in maintaining cellular identities by regulating cell‐type specific gene
expression programs. Based on this theory, direct reprogramming
was aimed at the forced expression of these key transcription factors
to activate the regulatory network supporting a specific cell fate.
During direct reprogramming, one somatic cell (e.g., fibroblast) is
transdifferentiated into another somatic cell (e.g., hepatocyte) with-
out intermediate stages of pluripotency. Due to this feature, direct
reprogramming represents a more reproducible and time‐efficient
technique compared with pluripotent stem cell‐based differentiation.
Direct reprogramming has been shown to allow the generation of
induced hepatocytes (iHeps) from many types of somatic cells
(Du et al., 2014; Huang et al., 2011; Sekiya & Suzuki, 2011). These
iHeps acquired hepatocyte function to some extent and could extend
the survival of mouse models with lethal liver disease after cell
transplantation. However, full maturation of these cells in vitro has
thus far not been achieved.
In the liver, hepatocytes are surrounded by extracellular matrix
(ECM), of which the dominant ECM components are collagens (type I,
III, IV, and V). Natural‐based ECM, especially type IV collagen, has been
routinely used for maintaining hepatocytes and iHeps (Huang et al.,
2011; LeCluyse, Bullock, & Parkinson, 1996). Apart from serving as the
scaffold for hepatocytes, ECM also performs signaling function by
storage and release of numerous growth factors, hormones, enzymes,
and cytokines. Considering the complexity of natural ECM, a single or
combination of several types of collagens may not be able to mimic
the genuine in vivo microenvironment for hepatocytes. Therefore, the
decellularized liver tissue may be a better alternative. Previously,
we and others have reported that decellularized liver tissue could
provide an excellent environment for the in vitro differentiation of
hepatic stem cells (Vyas et al., 2018; Wang et al., 2011) as well as
maintenance of primary hepatocytes (Soto‐Gutierrez et al., 2011).
However, it is still unknown whether iHeps can repopulate decellular-
ized liver tissue and whether the maturation of iHeps can be enhanced
by this more natural environment.
In this study, we report the efficient generation of iHeps from
mouse embryonic fibroblasts (MEFs) using a polycistronic system
expressing transcription factors including Forkhead Box A3 (Foxa3),
HNF1 Homeobox A (Hnf1α), and GATA Binding Protein 4 (Gata4).
Different from previously used combinations of separate vectors,
each encoding one or two genes, the all‐in‐one polycistronic
expression system induces homogenous iHep population as well as
fluorescent marker. These iHeps morphologically and functionally
resemble primary hepatocytes. Furthermore, we demonstrate that
iHeps can repopulate decellularized liver tissue. More important,
iHeps cultured with decellularized liver tissue exhibit high level of
maturation. This iHep‐on‐decellularized‐liver‐tissue system may
serve as an optimal model for drug activity and toxicity screening.
2 | MATERIAL AND METHODS
2.1 | Assembly of polycistronic lentiviral vectors
To construct the lentiviral hepatocyte‐generating vector, we used a
third‐generation lentiviral vector (pRRL‐PPT‐SFFV‐OKSM‐EGFP,
kindly provided by A. Schambach, Hannover, Germany; Warlich
et al., 2011). The region encoding Oct4, Klf4, Sox9, and Myc (OKSM)
was removed from the original vector by BamHI (New England
Biolabs, Ipswich, MA) digestion. The three modules encoding FOXA3‐
T2A, HNF1A‐E2A, and GATA4 were amplified by polymerase chain
reaction with monocistronic vectors separately expressing Foxa3,
Hnf1a, and Gata4 (FHG) as templates (kindly provided by L. Hui,
Shanghai, China; Huang et al., 2011). Each of these modules
contained 15‐bp overlaps at their ends. Ligation of all the modules
was based on the In‐Fusion HD Cloning system (Clontech Labora-
tories Inc, Mountain View, CA), in which the In‐Fusion enzyme can
fuse all the modules and the backbone by recognizing 15‐bp overlaps
at their ends.
2.2 | Cell culture, lentivirus production, and
lentiviral transduction
The human embryonic kidney line (HEK) 293T and mouse
embryonic fibroblasts were cultured in Dulbeccoʼs modified Eagleʼs
medium (DMEM, Gibco, Dublin, Ireland) supplemented with 10% v/
v fetal bovine serum (FBS, Gibco) and 1% v/v penicillin/streptomy-
cin. Primary hepatocytes were isolated by a two‐step perfusion
procedure from C57BL/6 mice (Severgnini et al., 2012). Viable
hepatocytes were isolated by Percoll medium according to the
manufacturerʼs instructions (GE Healthcare, Chicago, IL).
Virus production was performed as previously described
(Nantasanti et al., 2015). In short, 7 × 106 HEK‐293T cells were
plated 24 hr before transfection (Day 1) in 15 cm dishes. On Day 0,
cells were transfected by linear polyethylenimine (PEI; Polysciences
Inc, Warrington, PA, 1 μg DNA: 5 μg PEI) with 45 μg lentiviral vector,
3.6 μg HDM‐Hgpm2, 3.6 μg RC‐CMV‐Rev1b, 3.6 μg HDM‐tat1b, and
7.2 μg HDM‐VSV‐G. Media was refreshed after 12–16 hr. Super-
natant containing virus was harvested on Days 2–4. On Day 4,
filtered supernatant was centrifuged at 72,000 g for 2 hr at 4°C. The
pellet was resuspended in 150 μl sterile phosphate‐buffered saline
(PBS) with 1% w/v bovine serum albumin, and aliquots were stored at
−80°C until use.
2.3 | Generation of iHeps
For viral transduction, on Day 0, MEFs were incubated with
concentrated lentivirus (1:10,000) containing the reprogramming
factors and 8 μg/ml of Polybrene (Sigma‐Aldrich, St. Louis, MO). On
Day 1, MEFs were washed by HBSS (Gibco) twice and cultured with
fresh MEF medium. On Day 2, iHep medium, containing a 1:1 mixture
of DMEM/F‐12, supplemented with 10% FBS, 20 ng/ml hepatocyte
growth factor, 20 ng/ml epidermal growth factor, 1 μg/ml insulin,
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10−7 M dexamethasone, 10mM nicotinamide, 2 mM L‐glutamine,
50 μM β‐mercaptoethanol, and 1% v/v penicillin/streptomycin. Cells
were surpassed on Days 7 and 14. The culture dishes were precoated
with type I collagen (Millipore, Burlington, MA). Medium was
refreshed every 2 days.
2.4 | RNA isolation, complementary DNA
synthesis, and RT‐qPCR
RNA was isolated from MEFs, primary hepatocytes, and two
dimension‐cultured iHeps using the RNeasy Micro Kit according to
the manufacturerʼs instructions (Qiagen, Hilden, Germany). For
isolating RNA from the iHeps on the disks, we first used PBS to
wash the disks, and then added lysis buffer (RLT buffer, from RNeasy
micro kit, Qiagen) directly. After 5min of incubation, all the lysates
were collected for further procedures. Complementary DNA (cDNA)
was obtained using the iScript™ cDNA synthesis kit as described by
the manufacturer (Bio‐Rad, Hercules, CA). Relative gene expression
of the selected genes was measured using RT‐qPCR. Primer design,
validation, RT‐qPCR conditions, and data analysis were performed as
previously described (van Steenbeek et al., 2013). Normalization was
performed using the reference gene hypoxanthine phosphoribosyl
transferase. Details of primers are listed in Table S1.
2.5 | Immunofluorescence analysis
Cells were fixed in 4% paraformaldehyde for 60min and permeabi-
lized with PBS containing 0.3% v/v Triton X‐100 for 30min. Cells
cultured on decellularized liver disks (DLD) were incubated with
0.01 g/ml NaBH4 solution to reduce the background generated by
the liver disks. Primary antibodies were incubated overnight.
Secondary antibodies were incubated at room temperature for
2 hr. Tissues were then incubated with 5 µM Alexa Fluor® 488
(Molecular Probes, Eugene, OR) or Alexa Fluor® 647 (for cells
cultured on DLD) according to the manufacturerʼs instructions.
Nuclei were stained with DAPI (Sigma‐Aldrich). Tissues were
mounted on slides with ProLong® Diamond Antifade Mounting
Medium (Molecular Probes). Images were acquired using the Leica
SPE‐II confocal system. Antibody details for each protein are shown
in Table S2.
2.6 | Immunoblot analysis
For primary mouse hepatocytes and transduced and untransduced
MEFs, whole cell lysates were prepared using radioimmunoprecipita-
tion assay (RIPA) lysis buffer containing 50mM Tris HCl, 150mM
NaCl, 1% v/v NP‐40, 0.25% w/v sodium deoxycholate, 1 mM
ethylenediaminetetraacetic acid, 1 mM sodium fluoride, 1 mM so-
dium orthovanadate, 1 µg/ml aprotinin, and 1mM phenylmethylsul-
fonyl fluoride (PMSF) (Sigma‐Aldrich). Protein concentration was
measured by the DC Protein Assay (Bio‐Rad). Fifty micrograms of
total protein for each sample was loaded in a 10% SDS‐PAGE gel,
transferred to a 0.45 μm nitrocellulose membrane (Bio‐Rad), and
blocked with the ECL Blocking agent (GE Healthcare). The blots were
probed with anti‐FOXA3 (Thermo Fisher Scientific, Waltham, MA,
PA1‐813, dilution 1:500), anti‐HNF1A (Thermo Fisher Scientific,
PA5‐35356, dilution 1:1,000), and anti‐GATA4 (Abcam, Cambridge,
UK, ab84593, dilution 1:1,000) overnight at 4°C and subsequently
incubated with HRP‐conjugated anti‐rabbit (R&D systems, Minnea-
polis, MI, HAF008, dilution 1:5,000) for 1 hr at room temperature.
Luminescence induced by the Amersham ECL western blot analysis
Detection Reagent (GE Healthcare) was measured with a ChemiDoc
XRS Imager (Bio‐Rad).
2.7 | Hepatocyte functional tests
For measurement of albumin (Alb) secretion, iHeps, MEFs, and
primary hepatocytes were cultured in serum‐free medium. After
24 hr, culture medium was collected. Protein in the medium was
concentrated using Amicon Ultra centrifugal filters (Millipore), and
the amount of Alb was measured using a DxC‐600 Beckman
chemistry analyzer (Beckman Coulter, Brea, CA). The values were
normalized for total cell number.
For the measurement of cytochrome P450 activity, iHeps, MEFs,
and primary hepatocytes were incubated in 50 μM luciferin‐PFBE
substrate (Promega, Madison, WI) in culture medium (Gibco)
containing 10% FBS for 8 hr at 37°C. Cyp3a activity was then
measured with a luminometer using the P450‐Glo cytochrome P450
assay kit according to the manufacturerʼs instructions (Promega).
For the measurement of the expression of hepatic enzymes in
two dimension‐cultured iHeps, cells were lysed in distilled water. The
alkaline phosphatase (ALP), gamma‐glutamyl transferase (GGT),
lactate dehydrogenase (LDH), glutamate dehydrogenase (GLDH),
and aspartate aminotransferase (AST) in the lysate were measured
using the DxC‐600 Beckman chemistry analyzer (Beckman Coulter),
and values were normalized to total cell number. For the measure-
ment of the expression of hepatic enzymes in DLD‐iHeps, two disks
of cells were pooled together to generate enough material for each
liver enzyme test as described above; the results of those tests were
normalized to the value of the alamarBlue test (Thermo Fisher
Scientific), which indicates the number of viable cells.
2.8 | Decellularized liver disk preparation
Briefly, livers from 4‐ to 8‐month‐old cadaveric rats were harvested
with intact vessels (the animals were previously used by other
researchers of our institution and killed on completion of their
institutional animal care and use committee (IACUC) approved
experiments). The livers were then cannulated through the portal
vein and successively perfused at the rate of 1ml/min with 0.5 L
distilled water, 5 L detergent comprising 1% v/v Triton‐X 100 (Sigma‐
Aldrich) and 0.1% v/v ammonium hydroxide (Sigma‐Aldrich), and 10 L
distilled water to wash out the decellularization detergent. Decel-
lularized livers with a level of DNA removal higher than 90% were
obtained with this method.
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To obtain liver disks, decellularized livers were cut into wedges
and embedded in plastic molds (Sakura Finetek, Europe, Alphen a/d
Rijn, the Netherlands) with OCT and frozen at −80°C. These
cryopreserved liver wedges were mounted onto a cryomicrotome
(CM 1950, Leica Biosystems, Nussloch, Germany) to obtain liver
ECM sections of 250 μm thickness. A 4‐mm‐diameter biopsy punch
was used to generate a disk from the liver sections, and the disks
were placed in 96‐well plates. After multiple washes with PBS, the
disks were sterilized by UV irradiation for 2 hr. Disks were stored in
PBS at 4°C until use.
2.9 | Recellularization of iHeps on DLD
The seeding procedure was performed as previously described (Vyas
et al., 2018). Briefly, 2.5 × 105 iHeps were suspended in 10 μl iHep
medium for each disk. Disks were placed in 96‐well round bottom
microwell plates (Nunc, Roskilde, Denmark). The cell suspension was
slowly pipetted on top of each disk and incubated for about an hour
at 37°C to allow the cells to attach. Afterwards, 200 μl additional
iHep medium was added to each well. As a two‐dimensional control,
the same number of iHeps were seeded on collagen (type I) coated
96‐well tissue culture plates.
2.10 | Statistical analysis
Statistical analysis and graphs were performed using GraphPad Prism
7.0 (GraphPad Software Inc., San Diego, CA). See the figure legends
for details on specific statistical tests run and p values calculated for
each experiment.
3 | RESULTS
3.1 | Design of lentiviral vectors inducing hepatic
reprogramming gene expression in mouse embryonic
fibroblasts
Previously, Warlich et al. (2011) developed a modular lentiviral vector
system for generating human and mouse pluripotent stem cells (iPSCs).
Apart from the region encoding the iPSC reprogramming factors (OKSM),
the main modules in this vector are spleen focus‐forming virus U3
promoter (SFFV), which has been proven to mediate efficient expression
in fibroblasts (Baum, Hegewisch‐Becker, Eckert, Stocking, & Ostertag,
1995); an internal ribosome entry site (IRES)‐driven fluorescence marker,
dTomato, for imaging/cell tracking studies; a posttranscriptional regula-
tory element derived from the woodchuck hepatitis virus to enhance
lentiviral vector titer and expression (Schambach et al., 2006); as well as
the necessary elements for lentivirus production (Figure 1a). Hepatocyte‐
generating factors FHG (Huang et al., 2011) were amplified indepen-
dently and inserted in the vector to replace OKSM. FHG were separated
by thosea asigna virus 2A (T2A) and equine rhinitis A virus 2A (E2A)
sequences, which have previously been shown to mediate complete
separation of recombinant proteins (Kim et al., 2011). MEFs were
transduced with FHG lentivirus and RNA and protein samples
were collected after 5 days. Gene expression analysis, using a qPCR
primer set amplifying the region on Hnf1α and E2A, confirmed the
exogenous expression of FHG (Figure 1b). Immunoblot analysis further
showed that FHG were highly expressed in transduced MEFs, whereas
they were not or very low expressed in untransduced MEFs (Figure 1c).
3.2 | Generation of mouse iHeps with the
polycistronic expression system
Previous studies showed that forced expression of a set of
transcription factors could reprogram MEFs into hepatocyte lineage
(Huang et al., 2011; Sekiya & Suzuki, 2011). This system however was
based on separate expression vectors, which led to uncertain
transduction of the individual genes in cells, leading to a hetero-
genous population. We questioned whether the all‐in‐one polycis-
tronic expression system could overcome this issue. MEFs were
transduced with the all‐in‐one lentivirus and fluorescence was
observed after 2 days, which indicates the successful transduction
and expression of exogenous genes (data not shown). Two days after
transduction we changed the MEF culture medium to iHep culture
medium (Figure 2a; medium components based on Sekiya and Suzuki
(2011)). After 2 weeks, we observed that almost 90% of the cells
were dTomato positive (Figure 2b). Besides, the cell morphology
changed from elongated to polygonal shape (Figure 2c), which is a
F IGURE 1 Design and efficacy of the polycistronic lentiviral
vector. (a) Modular configuration of the self‐inactivating (SIN) vector
backbones for expression of the hepatocyte transcription factors
Foxa3, Hnf1α, and Gata4. (b) Relative mRNA expression of the
exogenous genes in MEFs without transduction (–) and with
transduction of FHG lentivirus after 5 days (+). Data are shown as
mean ± SEM of three independent experiments for each group.
(c) Protein expression of FOXA3, HNF1A, GATA4, and ACTB in
untransduced (–) and transduced (+) MEFs. ψ: packaging signal;
cPPT: central polypurine tract; FHG: Foxa3, Hnf1α and Gata4;
Foxa3: Forkhead Box A3; Gata4: GATA Binding Protein 4; Hnf1α:
HNF1 Homeobox A; IRES: internal ribosomal entry site; MEF: mouse
embryonic fibroblasts; LTR: long terminal repeat; RRE:
rev‐responsive element; SA: splice acceptor; SEM: standard error
of the mean; SFFV: spleen focus‐forming virus U3 promoter;
UD: undetectable; WPRE: woodchuck hepatitis virus [Color figure
can be viewed at wileyonlinelibrary.com]
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typical phenotype of hepatocytes. We designated these cells induced
hepatocytes or iHeps.
Gene expression analysis demonstrated little expression of mesench-
ymal marker snail family transcriptional repressor 2 and fibroblast
marker collagen type I alpha 1 chain in iHeps (Figure 3a). In contrast,
epithelial marker cadherin 1 (Cdh1, also known as E‐cadherin) was highly
expressed in iHeps (Figure 3a), which indicates the mesenchymal‐
epithelial transition of cell fate. Furthermore, iHeps displayed increased
expression of the following hepatocyte markers: Alb, cytochrome P450
family 1 subfamily A member 2 (Cyp1a2), cytochrome P450 family
3 subfamily A member 11 (Cyp3a11), ATP binding cassette subfamily C
member 2 (Abcc2), alpha fetoprotein (Afp), hepatocyte nuclear factor
4 alpha, transthyretin, and transferrin (Figure 3a). The cholangiocyte or
hepatic progenitor markers SRY‐box 9 (Sox9) and HNF1 homeobox B
(Hnf1b) were expressed but at significantly lower levels compared with
organoid‐derived cholangiocytes generated by previous protocol (un-
published data). Immunofluorescence analysis confirmed the presence of
hepatocyte markers (CYP1A2 and HNF4A) and epithelial markers (CDH1
and tight junction protein 1 [TJP1]), and the absence of cholangiocyte
markers (solute carrier family 10 member 2 [SLC10A2] and HNF1B;
Figure 3b). Together, these results showed that direct reprogramming,
through an all‐in‐one polycistronic expression system, can induce MEFs
to iHeps without inducing differentiation into the cholangiocyte lineage.
3.3 | Functional validation of iHeps
Next, we investigated whether the iHeps generated by the all‐in‐one
polycistronic expression system functionally resembled primary hepa-
tocytes. AST, LDH, and LDH are intracellular enzymes catalyzing
important metabolism functions, and they are specifically expressed in
hepatocytes in the liver (Gowda et al., 2009; Jaeschke & McGill, 2013;
Kotoh et al., 2011). We collected lysate from MEFs, iHeps, and primary
hepatocytes, and measured their enzyme activities. Figure 4 shows that
the activities of AST and LDH in iHeps were upregulated (Figure 4a,b),
but GLDH activity remained at similar levels compared with MEFs
(Figure 4c). LDH levels were similar to those observed in primary
hepatocytes. Notably, GLDH is predominantly located in the
centrilobular (Zone 3) region of the liver, whereas AST is more
homogenously distributed (Dancygier, 2010), indicating that iHeps
might represent hepatocytes with noncentrilobular origin. Besides, GGT
and ALP, which are related to biliary tracts, were undetectable in MEFs,
iHeps, and primary hepatocytes (data not shown), confirming the
nonbiliary fate of iHeps.
The cytochrome P450 enzymes (CYP) are essential in drug
metabolism, in particular CYP3A4 (mouse homologous isoforms are
CYP3A11, CYP3A16, CYP3A41A, CYP3A41B, and CYP3A44; Cui,
Renaud, & Klaassen, 2012). In iHeps, we observed that the CYP3A
activity was induced to almost one third of the levels compared with
primary hepatocytes (Figure 4d). Another key function of hepatocytes is
producing serum proteins; therefore, we examined the Alb concentration
in culture medium of iHeps. As Figure 4e shows, Alb was detectable in
iHep culture medium reaching about half the concentration in primary
hepatocyte culture medium.
3.4 | Repopulation of DLD by iHeps
Previously we and others have reported that hepatic stem cells and
primary hepatocytes could repopulate decellularized liver tissue
F IGURE 2 Generation of iHeps from MEFs and morphology. (a) Schematic showing the generation of iHeps. Cells were cultured in MEF
medium for 2 days after transduction. From Day 2, cells were cultured in iHep medium. Cells were subcultured twice around Day 7 and Day 14,
when reaching confluency. (b) Representative flow cytometry analysis of dTomato expression in untransduced MEFs (left) and iHeps (Day 16,
right). (c) Morphology of untransduced MEFs cultured in MEF medium (left) and iHep medium (middle) and iHeps (right) in iHep medium for 16
days. Scale bar = 100 μm. MEFs: mouse embryonic fibroblasts [Color figure can be viewed at wileyonlinelibrary.com]
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(Baptista et al., 2011; Soto‐Gutierrez et al., 2011; Vyas et al., 2018;
Wang et al., 2011). We questioned whether iHeps also possessed the
repopulation capacity. When iHeps were seeded on rat DLD, we
found they survived and could repopulate DLD within 1 week
(Figure 5a). In contrast, nonreprogrammed MEFs seeded on DLD did
not survive (data not shown).
Because the ECM in DLD represents a natural habitat for
hepatocytes, we determined whether DLD could further enhance the
maturation of iHeps. Gene expression analysis demonstrates that
cytochromes P450 including Cyp1a1, Cyp1a2, Cyp2c40, Cyp3a11, and
Cyp3a13, and epithelial marker Cdh1, were dramatically upregulated,
whereas the early hepatocyte marker Afpwas downregulated (Figure 5b).
F IGURE 3 Characterization of iHeps.
(a) Gene expression analysis for MEFs, iHeps,
primary mouse hepatocytes (PHs), and
primary cholangiocytes. Data are shown as
mean± SEM of four independent samples for
each group. The asterisk represents statistical
significance. *p<0.05. The hash represents
nonsignificance (two‐tailed Mann–Whitney
U test). Hepatocyte markers, albumin (Alb),
cytochrome P450 3a11 (Cyp3a11),
cytochrome P450 1a2 (Cyp1a2), and ATP
binding cassette subfamily C member 2
(Abcc2); epithelial marker, caderin1 (Cdh1);
mesenchymal marker, snail family
transcriptional repressor 2 (Snai2); fibroblast
marker, collagen type I alpha 1 chain (Col1a1);
cholangiocyte/hepatic progenitor markers,
SRY‐box 9 (Sox9) and HNF1 homeobox B
(Hnf1b). (b) Immunofluorescence analysis for
iHeps. Hepatocyte markers, CYP1A2 and
hepatocyte nuclear factor 4 alpha (HNF4A);
epithelial markers, CDH1 and tight junction
protein 1 (TJP1); cholangiocyte markers,
solute carrier family 10 member 2 (SLC10A2)
and HNF1B. Nuclear staining with 4′,
6‐diamidino‐2‐phenylindole dihydrochloride
(DAPI) for all conditions. Scale bar = 30 μm
[Color figure can be viewed at
wileyonlinelibrary.com]
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Interestingly, we observed that Alb and exogenous FHG were
significantly downregulated (Figure 5b,d). Immunofluorescence analysis
demonstrates the expression of CYP1A2 and TJP1 (Figure 5c). Finally,
iHeps cultured with DLD exhibited the increased enzyme activity of LDH,
GLDH, CYP3A, and CYP1A2 (Figure 5d), whereas GGT and ALP activity
were undetectable (data not shown). Together, these results indicate that
iHeps reached a high level of maturation. Although Alb expression was
downregulated, the iHep‐on‐decellularized‐liver‐tissue system still repre-
sents an excellent model for phase I drug metabolism studies.
4 | DISCUSSION
Direct reprogramming of fibroblasts into hepatocytes is time‐saving
and requires less effort due to the bypass of an intermediate stage of
pluripotency; hence, it represents an optimal way to quickly generate
a large population of cells. The heterogeneity of iHeps and their lack
of liver function may be due to the uncontrollable expression
proportion of hepatocyte‐generating factors FHG separately by
means of monocistronic vectors. To overcome this issue, an all‐in‐
one polycistronic expression system is needed. The classical and
widely used way to construct bicistronic or polycistronic vectors is to
insert an IRES between genes. Because of its large molecular size and
the difference in expression levels between genes before and after
IRES (the gene before IRES generally has disproportional higher
expression), we used the 2A peptide sequence insert in this study.
This 2A peptide sequence is usually 50–60 bp compared with around
580 bp of IRES, which enables the construction of vectors containing
four or even more encoding regions. This is especially important for
a lenti‐ and retroviral expression system, of which the size of
packaged sequence is limited (Kumar, Keller, Makalou, & Sutton,
2001). Besides, genes before and after the 2A peptides are separated
from each other during posttranslational modification by a highly
efficient cleavage event; therefore, functional proteins can be
obtained. The all‐in‐one polycistronic expression system used in this
study induced high expression of all genes at messenger RNA and
protein level, which allowed the generation of iHeps.
During in vitro culture at normal conditions MEFs become
senescent or reach their Hayflick limit, after 5–7 passages (Amand,
Hanover, & Shiloach, 2016). To our surprise, the transduced MEFs or
iHeps (transduction performed at passage 4) continued to grow for at
least 30 passages over 2 months (longer term to be determined). This
growth advantage of iHeps provided us an easy way to select the
positive cells over untransduced MEFs. We observed that almost
90% cells were dTomato positive after 2 weeks and their morphology
was identical after two passages (Figure 2). With further (sub)culture,
this percentage kept increasing and a homogenous population was
generated without the need of fluorescence‐activated cell sorting. As
hepatocytes do not proliferate in vitro, the continued proliferation of
iHeps indicates that these cells are not fully mature, which is also
reflected by other results, such as high expression of the early
hepatocyte marker Afp and relatively low expression of the late
F IGURE 4 Functional validation of iHeps. Relative activity of hepatocyte‐specific enzymes (a–c), Cyp3a activity (d), and albumin secretion
(e) in MEFs, iHeps, and primary hepatocytes. Results were normalized with cell number. Normalized data are shown as mean ± SEM of four
independent experiments for primary hepatocytes and six independent experiments for MEFs and iHeps (P17). The asterisk represents
statistical significance. *p < 0.05. *p < 0.01. The hash represents nonsignificance (two‐tailed Mann–Whitney U test). AST: aspartate
aminotransferase; LDH: lactate dehydrogenase; GLDH: glutamate dehydrogenase; MEFs: mouse embryonic fibroblasts; SEM: standard error of
the mean
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hepatocyte markers Cyp3a11 and Cyp1a2 (Figure 3). Nevertheless,
this is a clear advantage when large numbers of cells are needed for
tissue engineering or cell therapy approaches.
To improve the maturation of iHeps, we introduced iHeps into
decellularized liver tissue. This natural‐based ECM, mainly containing
collagens, laminin, and fibronectin, does not only provide mechanical
and structural support for cells, but also serves as the reservoir for
growth factors like HGF and bFGF (Soto‐Gutierrez et al., 2011). After
seeding on DLD, we observed that the exogenous expression of FHG
was downregulated. This explains that Alb, a direct downstream target
of these three transcription factors (Cirillo et al., 2002; Kajiyama, Tian,
& Locker, 2006; Lichtsteiner & Schibler, 1989), also showed lower
expression. Although the precise mechanism behind the quenching of
exogenous gene expression is unknown, it is a relatively common
phenomenon during cell fate reprogramming (Huang et al., 2011;
Takahashi & Yamanaka, 2006) and indicates the dominance of the
microenvironment. Having said this, the drug metabolism potential
(Cyp3a11 and Cyp1a2) of iHeps was greatly enhanced and reached
levels that were close to primary hepatocytes. The generation of the
DLD is relatively easy and highly reproducible (Wang et al., 2017). The
combined robust differentiation capability together with the disks
results in a liver model that is more representative of the native liver
tissue and has comparable hepatic features. These results indicate that
the iHep‐on‐decellularized‐liver‐tissue system may represent an
excellent model for phase I drug metabolism studies.
There are a few limitations in this study. The primary mouse
hepatocytes were isolated by a two‐step collagen perfusion method
(Walker, Jackson, Taylor, Jones, & Forrester, 2010). Although the
F IGURE 5 Repopulation of decellularized liver disks by iHeps. (a) Hematoxylin and eosin (H&E) staining showing the repopulation of
decellularized liver disks by iHeps after 1 week. Scale bar = 50 μm. (b) Immunofluorescence analysis for iHeps cultured on decellularized liver
disks (DLD). Scale bar = 20 μm. (c) Gene expression analysis for iHeps cultured on collagen (type I) coated plates (Col) and DLD. (d) Relative
activity of hepatocyte‐specific enzymes (AST, LDH, GLDH), CYP3A and CYP1A2 activity and albumin secretion in iHeps cultured on Col and
DLD. All results were normalized with cell input with Alamar blue. Data are shown as mean ± SEM of six independent experiments for collagen
2D cultured iHeps for AST, LDH, GLDH and albumin tests, three for DLD cultured iHeps for AST, LDH, GLDH and albumin tests, four for both
2D and DLD cultured iHeps for CYP3A and CYP1A2 tests. The asterisk represents statistical significance. *p < 0.05. The hash represents
nonsignificance (two‐tailed Mann–Whitney U test) [Color figure can be viewed at wileyonlinelibrary.com]
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majority of the isolated population were hepatocytes, the presence of
some other unwanted cell types (e.g., hepatic stellate cells, cholangiocytes,
etc.) is inevitable. Therefore, we used a commercial media designated for
hepatocytes culture (HepatoZYME; Gibco) to select out other cell types.
Because in vitro hepatocytes cultures could de‐differentiate rapidly
(Chen, Wong, Sjeklocha, Steer, & Sahin, 2012), our culture of 2 days
before measurement could have influenced the results. This limitation
could be overcome by utilizing freshly isolated pure hepatocytes (e.g., by
sorting ASGPR+ cells; Severgnini et al., 2012) as the most optimal
reference cell type. Second, the decellularized liver tissue used in this
study was derived from rats as no decellularized mouse material was
available. The species incompatibility of mouse cells and rat ECM might
limit the full maturation potential of iHeps.
5 | CONCLUSION
Here we reported an easy and efficient way to generate expandable
iHeps. Applying decellularized liver tissue to the in vitro culture
resulted in iHeps with enhanced hepatic features. Our finding
demonstrates that hepatic ECM can induce important functions of
iHeps derived from somatic cells by direct reprogramming. Future
research may focus on introducing supporting cell types (e.g., hepatic
stellate cells, mesenchymal stromal cells, endothelial cells, etc.) to the
current system to generate an even more physiological microenvir-
onment for hepatocytes.
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